Page results
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page explains what FACETS is and how it can help you.
-
Miss Nathalie Zaidman is a consultant spinal neurosurgeon specialising in complex spinal surgery.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients